Becton, Dickinson Shareholders Approve All Proposals at Annual Meeting, Recap Record FY2025

• Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs

Becton, Dickinson and Company (NYSE:BDX) shareholders approved each 4 proposals presented astatine the company’s yearly meeting, including the predetermination of directors and an amendment to the company’s equity compensation plan, according to preliminary voting results shared during the event.

The gathering docket included 4 items described successful the proxy statement: (1) predetermination of manager nominees to one-year terms, (2) ratification of Ernst & Young arsenic BD’s autarkic registered nationalist accounting steadfast for fiscal 2026, (3) an advisory “Say connected Pay” ballot connected named enforcement serviceman compensation, and (4) support of an amendment to BD’s 2004 Equity Compensation Plan. The institution noted that Ernst & Young representatives Matt Askins and Jared Santisi participated successful the meeting.

→ Microsoft Drops After Earnings—Why the Bull Case Holds

• Healthcare Stocks With astatine Least 30 Years of Dividend Increases

Management utilized the gathering to reappraisal BD’s fiscal 2025 results, describing the twelvemonth arsenic some the culmination of the company’s BD 2025 strategy and the commencement of a caller signifier of growth. The institution besides referenced forward-looking statements and directed investors to disclosures and reconciliations betwixt GAAP and non-GAAP measures successful its presumption materials and SEC filings.

For fiscal 2025, BD reported grounds gross of $21.8 billion, representing 7.7% maturation connected an adjusted overseas exchange-neutral basis and 2.9% integrated growth. Management said “New BD” delivered 3.9% integrated gross growth, citing coagulated maturation crossed cardinal platforms amid a “dynamic marketplace environment.”

→ Meta Soars After-Hours, Forecasting Fastest Growth Since 2021

The institution said its BD Excellence operating strategy contributed to nett and nonaccomplishment leverage during the year, including:

• Adjusted gross borderline up 140 ground points

• Adjusted operating borderline enlargement of 80 ground points

• 9.6% adjusted diluted EPS growth, inclusive of tariffs

• Achievement of a full-year extremity to scope a record 25% adjusted operating margin

BD besides said it returned $2.2 billion to shareholders successful 2025, including a $1 cardinal stock repurchase. The institution announced its 54th consecutive twelvemonth of dividend increases, extending its presumption arsenic a subordinate of the S&P 500 Dividend Aristocrats Index.

→ Palantir Bulls Face a Reality Check Before Earnings

Looking backmost implicit the past 5 years nether the BD 2025 strategy, absorption said the institution delivered what it described arsenic the astir prolific play of maturation successful its 128-year history, adding much than $5.4 cardinal successful integrated revenue and gathering respective caller platforms. The institution highlighted maturation areas including biologic cause delivery, insubstantial regeneration, urinary incontinence, pharmacy robotics, and precocious diligent monitoring.